DHR's fourth-quarter sales increase 2.1% year over year, benefiting from the solid performance of its Life Sciences and Biotechnology segments.
Vous n'êtes pas connecté
ENS' fiscal Q3 net sales increase 5.2% driven by the impressive performance of its operating segments.
DHR's fourth-quarter sales increase 2.1% year over year, benefiting from the solid performance of its Life Sciences and Biotechnology segments.
JCI's fiscal first-quarter revenues increase 10% year over year, driven by strength in the HVAC & controls businesses.
RTX's Q4 sales of $21.62 billion surpass the Zacks Consensus Estimate by 5.2%. The metric also surges a solid 8.5% from the prior-year level.
BERY's first-quarter fiscal 2025 net sales increase 2% year over year, driven by higher selling prices.
EMR's first-quarter fiscal 2025 revenues inch up 1% year over year, driven by strength in its Software and Control segment.
RYAAY expects its fiscal 2025 traffic to grow 9% (prior view: up 8%) on a year-over-year basis, subject to no further adverse news on Boeing delivery...
While the top- and bottom-line numbers for EnerSys (ENS) give a sense of how the business performed in the quarter ended December 2024, it could be...
EnerSys (ENS) delivered earnings and revenue surprises of 2.97% and 3.04%, respectively, for the quarter ended December 2024. Do the numbers hold...
BAH's third-quarter fiscal 2025 earnings and revenues increase year over.
Strength in the Fire & Safety/Diversified Products segment aids IEX's fourth-quarter results.